Clinical Trial: A multicenter real-world study on the efficacy, safety, and optimal dosage of deuterobenzazine tablets for the treatment of tardive dyskinesia (China)

Posted On: 2026-09-11

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter real-world study on the efficacy, safety, and optimal dosage of deuterobenzazine tablets for the treatment of tardive dyskinesia'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132199

Registration Time: 2026/09/10

Type: Observational study

Primary Sponsor: CHAOHU HOSPITAL OF ANHUI MEDICAL UNIVERSITY

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341448

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A multicenter real-world study on the efficacy, safety, and optimal dosage of deuterobenzazine tablets for the treatment of tardive dyskinesia (China)